OASMY (Vivesto AB) Issuance of Stock : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB Issuance of Stock?

Vivesto AB's Issuance of Stock for the three months ended in Sep. 2024 was $0.00 Mil.

Vivesto AB's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Vivesto AB Issuance of Stock Historical Data

The historical data trend for Vivesto AB's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Issuance of Stock Chart

Vivesto AB Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Dec21

Dec22

Dec23

Issuance of Stock

Get a 7-Day Free Trial

17.69

47.28

14.52

Vivesto AB Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Issuance of Stock	Get a 7-Day Free Trial															-	-	-	-	-

Vivesto AB Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Vivesto AB Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivesto AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

VIVE:Sweden OMAX:Germany

Address

Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73

Website

https://www.vivesto.com

Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.